NYKODE THERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.27 NOK | -1.63% |
|
-13.21% | -37.99% |
| 20/06 | Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting | CI |
| 11/06 | Nykode Therapeutics ASA Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 418M | - | |||||
| 122B | ||||||
| 112B | ||||||
| 19.33B | - | |||||
| 16.17B | ||||||
| 15.6B | - |
- Stock Market
- Equities
- VACC Stock
- Charts Nykode Therapeutics
- Sector Chart
